Rahlfs Capital
BMY icon

Rahlfs Capital’s Bristol-Myers Squibb BMY Stock Holding History

Rahlfs Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.24M Hold
19,851
– – 0.83% 35
2026
Q2 		$1.14M Hold
19,851
– – 0.84% 36
2026
Q1 		$1.2M Sell
19,851
-110
-0.6% -$6.41K 0.88% 38
2025
Q4 		$1.08M Hold
19,961
– – 0.84% 36
2025
Q3 		$900K Sell
19,961
-1,000
-5% -$46.7K 0.71% 42
2025
Q2 		$970K Hold
20,961
– – 0.89% 36
2025
Q1 		$1.28M Hold
20,961
– – 1.28% 23
2024
Q4 		$1.19M Buy
+20,961
New +$1.17M 1.17% 24

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Rahlfs Capital's BMY Position: Q3 2026 in Review

Rahlfs Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 19,851 shares worth $1.24M. The position accounts for 0.83% of the portfolio, ranked #35.

Rahlfs Capital first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.28M in Q1 2025. 1,618 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Rahlfs Capital held 19,851 shares of Bristol-Myers Squibb worth $1.24M as of Q3 2026.
  • Rahlfs Capital left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.83% of Rahlfs Capital's portfolio in Q3 2026, its #35 holding.
  • Rahlfs Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • Rahlfs Capital's Bristol-Myers Squibb position peaked at $1.28M in Q1 2025.
  • 1,618 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Rahlfs Capital's 13F filing for Q3 2026, filed 23 Oct 2026.